ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jul 16, 2014
Johnson & Johnson: Beat and Raise
We like this dividend growth giant quite a bit.
Jul 16, 2014
Valuentum's July Edition of Its Best Ideas Newsletter!
The July edition of our Best Ideas Newsletter is now available.
Jul 14, 2014
Beer and Cigarettes
Let’s take a look at potential consolidation in the alcoholic beverage and tobacco industries.
Jul 12, 2014
eBay is One of the Cheapest Stocks on the Market
eBay’s same-store sales data indicates the firm is back on track.
Jul 11, 2014
There’s No Space Like Aerospace
We continue to like firms with heavy exposure to the burgeoning aerospace industry.
Jul 9, 2014
Ford’s China Sales Continue to Impress
Though Ford’s market share in China trails that of peers, the automaker’s formula in the country is working. We expect Ford to be the biggest upside surprise in China in coming years.
Jun 28, 2014
Sizing Up Dividends in the Homebuilding Industry
Let's evaluate the health and strength of the dividend of the highest-yielding homebuilder.
Jun 23, 2014
Why Analytical Experience Matters
Dividend growth investors -- or any investor for that matter -- shouldn’t just plug and chug numbers. An understanding of the firm and its industry is vital to making sure the company can sustainably pay dividends through the course of the economic cycle.
Jun 23, 2014
GE ‘Wins’ Alstom’s Assets
GE prevails over Siemens-Mitsubishi consortium.
Jun 17, 2014
Firms Leaving United States for More Reasonable Tax Rates Elsewhere
Medtronic is the latest firm to pursue tax inversion via its tie-up with Covidien. Importantly, however, the firm renewed its commitment to dividend growth shareholders, hiking the payout 9%.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.